Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma

Clinical trial NCT05726383 · RECRUITING

Trial details

NCT number: NCT05726383
Sponsor: Hackensack Meridian Health
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Osteogenic Sarcoma Recurrent

Start date: 2024-05-14
Primary completion: 2027-05-11
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.